You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 7,601,730


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,601,730
Title:Carboxylic acid derivatives, their preparation and use
Abstract:Carboxylic acid derivatives ##STR00001## where R--R.sup.6, X, Y and Z have the meanings stated in the description, and the preparation thereof, are described. The novel compounds are suitable for controlling diseases.
Inventor(s): Riechers; Hartmut (Neustadt, DE), Klinge; Dagmar (Heidelberg, DE), Amberg; Wilhelm (Friedrichsdorf, DE), Kling; Andreas (Mannheim, DE), Muller; Stefan (Speyer, DE), Baumann; Ernst (Dudenhofen, DE), Rheinheimer; Joachim (Ludwigshafen, DE), Vogelbacher; Uwe Josef (Ludwigshafen, DE), Wernet; Wolfgang (Hassloch, DE), Unger; Liliane (Ludwigshafen, DE), Raschack; Manfred (Weisenheim, DE)
Assignee: Abbott GmbH & Co. KG (Wiesbaden, DE)
Application Number:11/502,293
Patent Claim Types:
see list of patent claims
Use; Delivery;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis of United States Patent 7,601,730

Introduction

When analyzing a U.S. patent, such as United States Patent 7,601,730, it is crucial to delve into the scope and claims of the patent, as well as the broader patent landscape. This analysis helps in understanding the patent's validity, its protection boundaries, and its position within the industry.

What is a U.S. Patent?

A U.S. patent is a grant of exclusive rights to an inventor for a new and useful process, machine, manufacture, or composition of matter, or any improvement thereof. The U.S. Patent and Trademark Office (USPTO) is responsible for issuing these patents after a thorough examination process[2].

The Importance of Claims in a Patent

The claims section of a patent application is the most critical part, as it defines the boundaries of patent protection. Claims are the legal descriptions of the invention that distinguish it from prior art and define what is protected by the patent. They must be clear, concise, and supported by the patent's description and drawings[2].

Analyzing the Claims of United States Patent 7,601,730

To analyze the claims of a specific patent like 7,601,730, one must:

Identify the Type of Patent

Determine whether the patent is a utility patent, design patent, or plant patent. Utility patents, the most common type, cover functional inventions.

Review the Claim Structure

Claims are typically divided into independent and dependent claims. Independent claims stand alone and define the invention broadly, while dependent claims refer back to and further limit the independent claims[2].

Understand Claim Language

Each claim must be written in a specific format and must clearly define the invention. The language used must be precise to avoid ambiguity and ensure that the claim is not overly broad or too narrow.

Evaluate Claim Scope

The scope of the claims determines what is protected by the patent. A Claim Coverage Matrix, as described in patent analytics, can help in understanding which patents and claims are actively protecting the intellectual property and where gaps or opportunities exist[3].

Patent Landscape Analysis

Prior Art and Novelty

Ensure that the invention is novel and non-obvious. This means it must not have been previously known, sold, or used by others or by the inventors themselves. The invention must also not be obvious to a person with ordinary skill in the relevant field[2].

Competitor Patents

Analyze competitor patents to identify potential overlaps or gaps in the patent landscape. This involves categorizing patents by claims and scope concepts to filter, search, and accurately analyze large numbers of patent claims concurrently[3].

International Considerations

If the patent has international implications, consider the differences in patent laws and filing requirements in other countries. For instance, while the U.S. has a one-year grace period for filing a patent application after public disclosure, most foreign countries do not[2].

Patent Prosecution and Examination

Filing Process

The patent prosecution process begins with the filing of a provisional or non-provisional patent application. For a U.S. utility patent, a provisional application can be filed first, followed by a non-provisional application within one year[2].

Examination by the USPTO

The USPTO reviews the application for patentability. This process can take two to five years and involves arguments and amended claims if the initial application is not patentable as submitted[2].

Appeals and Rejections

If the patent examiner issues a final rejection, the applicant can appeal to the Patent Trial and Appeal Board (PTAB) or the U.S. court system. Successful appeals can lead to claim allowance, while unsuccessful ones may result in the patent application being abandoned[2].

Patent Term and Adjustments

Patent Term

The term of a U.S. utility patent is generally 20 years from the earliest filing date of the application. However, this term can be adjusted due to delays in the prosecution process, such as those caused by the USPTO or derivation proceedings[4].

Terminal Disclaimers

In cases of obviousness-type double patenting (ODP), terminal disclaimers may be used to overcome rejections. These disclaimers affect the patent term and ensure that the inventor does not secure a second, later-expiring patent for the same invention[4].

Claim Construction and Validity

Claim Construction

Claim construction is a critical step in determining the scope of the patent. It is a question of law reviewed de novo on appeal. The construction of claim terms must be clear and consistent with the patent's specification and prosecution history[5].

Presumption of Validity

U.S. patents are accompanied by a presumption of validity. This means that the patent is assumed to be valid unless proven otherwise through invalidity challenges such as inter partes review (IPR) or litigation[5].

Key Takeaways

  • Claims are Crucial: The claims section of a patent defines the boundaries of patent protection and must be clear, concise, and supported by the patent's description.
  • Patent Landscape: Analyzing the patent landscape involves reviewing prior art, competitor patents, and international considerations.
  • Prosecution Process: The patent prosecution process includes filing, examination, and potential appeals, which can significantly impact the patent's validity and term.
  • Claim Construction: Claim construction is a legal question that determines the scope of the patent and is reviewed de novo on appeal.
  • Presumption of Validity: U.S. patents are presumed valid unless proven otherwise through legal challenges.

FAQs

Q: What is the primary purpose of the claims section in a patent application?

A: The primary purpose of the claims section is to define the boundaries of patent protection and distinguish the invention from prior art.

Q: How long does the patent prosecution process typically take?

A: The patent prosecution process can take two to five years, depending on the complexity of the invention and the need for arguments and amended claims.

Q: What is the significance of a provisional patent application?

A: A provisional patent application allows the inventor to file for patent protection without the formalities of a non-provisional application and provides a one-year period to decide whether to proceed with a non-provisional application.

Q: Can a patent term be extended due to delays in the prosecution process?

A: Yes, the patent term can be extended due to delays caused by the USPTO or other factors, such as derivation proceedings or appeals.

Q: What is the presumption of validity in U.S. patents?

A: U.S. patents are presumed valid unless proven otherwise through invalidity challenges such as inter partes review (IPR) or litigation.

Sources

  1. BitLaw: Patent Law in the United States.
  2. KU Office of Research: Intellectual Property Protection.
  3. Schwegman Lundberg & Woessner: Patent Analytics.
  4. United States Court of Appeals for the Federal Circuit: In re Cellect.
  5. United States Court of Appeals for the Federal Circuit: VASCULAR SOLUTIONS LLC v. MEDTRONIC, INC.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,601,730

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,601,730

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
GermanyP 44 36 851Oct 14, 1994
Germany195 33 023Sep 07, 1995

International Family Members for US Patent 7,601,730

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0785926 ⤷  Subscribe CA 2008 00037 Denmark ⤷  Subscribe
European Patent Office 0785926 ⤷  Subscribe 91487 Luxembourg ⤷  Subscribe
European Patent Office 0785926 ⤷  Subscribe 300361 Netherlands ⤷  Subscribe
European Patent Office 0785926 ⤷  Subscribe SPC029/2008 Ireland ⤷  Subscribe
European Patent Office 0785926 ⤷  Subscribe 08C0041 France ⤷  Subscribe
European Patent Office 0785926 ⤷  Subscribe SPC/GB08/047 United Kingdom ⤷  Subscribe
European Patent Office 0785926 ⤷  Subscribe C00785926/01 Switzerland ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.